On the necessity of legal statement of the procedure of accreditation of medical organizations for the right to conduct clinical studies of drugs for medical use

Abstract

The article is devoted to the problems of legislative regulation of the accreditation procedure for medical organizations for the right to conduct clinical trials of drugs for medical use. The author examines the possible reasons, the consequences of canceling the accreditation of medical organizations for the right to conduct clinical trials of drugs for medical use, and also substantiates the position on the need to revise the decision adopted by the legislative authorities, suggests ways to solve the problem, in particular, makes a proposal on the need to develop measures aimed at providing additional guarantees of state support for medical organizations that have passed the accreditation procedure, as well as increasing the motivation of medical personnel responsible for conducting and obtaining the results of clinical trials of drugs, in order to maintain a high level of medical care provided and maintain high standards for conducting clinical trials.